‘Engagement’ of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework Patrick BrownPriya Bahri Review Open access 25 June 2019 Pages: 1181 - 1192
Regulatory characteristics and pivotal study design of US Food and Drug Administration approval of drugs for major vs. minor cancer Kenji YamashitaMasayuki KanekoMamoru Narukawa Clinical Trial 25 May 2019 Pages: 1193 - 1200
Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI—the POPular Risk Score study Paul W. A. JanssenThomas O. BergmeijerJurriën M. ten Berg Pharmacogenetics 14 June 2019 Pages: 1201 - 1210
Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity Madelé van DykJohn O. MinersAndrew Rowland Pharmacokinetics and Disposition 23 May 2019 Pages: 1211 - 1218
Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient? A. J. HeffernanA. GermanoE. Kimura Pharmacokinetics and Disposition 01 June 2019 Pages: 1219 - 1226
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents Kayode OgungbenroJonathan B. WagnerAleksandra Galetin Pharmacokinetics and Disposition Open access 06 June 2019 Pages: 1227 - 1235
Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment Janine ZiemannAnnette LendeckelChristoph A. Ritter Pharmacokinetics and Disposition 01 June 2019 Pages: 1237 - 1248
Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study Joanna SobiakMatylda ResztakMaria Chrzanowska Pharmacokinetics and Disposition Open access 06 June 2019 Pages: 1249 - 1259
Towards a “prescribing license” for medical students: development and quality evaluation of an assessment for safe prescribing David R. M. JansenCarolina J. P. W Keijsers(on behalf of the education working group of the Dutch Society for Clinical Pharmacology and Biopharmacy) Pharmacoepidemiology and Prescription Open access 18 May 2019 Pages: 1261 - 1268
Medication errors in hospitals in the Middle East: a systematic review of prevalence, nature, severity and contributory factors Binny ThomasVibhu PaudyalDerek Stewart Pharmacoepidemiology and Prescription Open access 24 May 2019 Pages: 1269 - 1282
Association between adherence to antihypertensive medications and health outcomes in middle and older aged community dwelling adults; results from the Irish longitudinal study on ageing Caroline A. WalshCaitriona CahirKathleen E. Bennett Pharmacoepidemiology and Prescription 12 June 2019 Pages: 1283 - 1292
Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis Parvati B. PatelTejas K. Patel Pharmacoepidemiology and Prescription 11 June 2019 Pages: 1293 - 1307
Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine Stefanie L. GroenlandRon H. J. MathijssenNeeltje Steeghs Point of View 07 June 2019 Pages: 1309 - 1318
Letter to editor: Clinically relevant drug–drug interactions among elderly people with dementia Carmen Aranda-SalazarJean Mendoza-RamosAlonso Soto Letter to the Editor 29 April 2019 Pages: 1319 - 1319
Letter to the Editor: Clinically relevant drug–drug interactions among elderly people with dementia Eva SönnerstamMaria SjölanderMaria Gustafsson Letter to the Editor 16 July 2019 Pages: 1321 - 1322
Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database Carla CarnovaleGiulia MosiniSonia Radice Letter to the Editor 14 June 2019 Pages: 1323 - 1325
Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics? Hugues MichelonA. DelahayeM. Herr Letter to the Editor 25 May 2019 Pages: 1327 - 1329
Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement Jennifer L. GoldmanWen-Hung ChungMunir Pirmohamed Correction 29 June 2019 Pages: 1331 - 1331